Specialty code 183500000X · Los Angeles, CA
NPI
1932586963
Since 2015
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1505 N Edgemont St Fl 2
Los Angeles, CA, 90027
Phone (323) 783-4690
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$6.0M
1,163 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Gloria S Cha prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 117 prescriptions and refills. In total Gloria S Cha wrote 1,163 Medicare prescriptions that cost $6.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 117 | 321 | 53 | $1.2M |
| Ritonavir Generic | 96 | 275 | 43 | $16K |
| Tivicay Dolutegravir Sodium | 74 | 208 | 32 | $512K |
| Darunavir Generic | 73 | 211 | 33 | $19K |
| Prezcobix Darunavir/Cobicistat | 72 | 214 | 30 | $536K |
| Isentress Raltegravir Potassium | 62 | 182 | 30 | $389K |
| Juluca Dolutegravir/Rilpivirine | 60 | 158 | 24 | $559K |
| Descovy Emtricitabine/Tenofov Alafenam | 56 | 162 | 31 | $339K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 52 | 140 | 24 | $504K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 50 | 137 | 22 | $493K |
| Etravirine Generic | 44 | 126 | 19 | $60K |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 40 | 114 | 27 | $1,968 |
| Atazanavir Sulfate Generic | 37 | 109 | 17 | $5,412 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 36 | 102 | 14 | $7,405 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 35 | 97 | 17 | $321K |
Brand drugs: 687 claims; generic drugs: 476 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gloria S Cha were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.